Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Held

Showing results (111-120 of 268) with videos related to

Pageof 27
Sort By:
Clinical Journal of Oncology Nursing|May 8, 1999
Symptom management for patients with pancreatic cancerJ Held-Warmkessel, H Volpe, A R Waldman
Archives of Sexual Behavior|July 1, 1976
Follow-up effects of a medical school course in human sexualityJ Garrard, A Vaitkus, J Held, et al.
Journal of Policy Analysis and Management : [The Journal of the Association for Public Policy Analysis and Management]|February 4, 1988
Privatization and bidding in the health-care sectorR R Bovbjerg, P J Held, M V Pauly
American Journal of Industrial Medicine|January 1, 1988
Mortality of aircraft manufacturing workers in southern CaliforniaD H Garabrant, J Held, B Langholz, et al.
International Journal of Cancer|April 17, 2001
Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cellsR Mentlein, O Eichler, F Forstreuter, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 30, 2001
Calculation and public use of the unit-specific standardized mortality ratioR A Wolfe, P J Held, F K Port
Journal of Physiology, Paris|November 23, 2000
Somatostatin receptors in gliomasJ Held-Feindt, B Krisch, F Forstreuter, et al.
Journal of Cardiovascular Risk|August 1, 1995
Comparison of two scoring systems used to monitor diets in outpatient clinical trialsW S Harris, S J Held, C A Dujovne
Brain Research. Molecular Brain Research|February 27, 2001
Influence of the somatostatin receptor sst2 on growth factor signal cascades in human glioma cellsJ Held-Feindt, F Forstreuter, T Pufe, et al.
The Milbank Quarterly|January 1, 1987
Provider-patient relations and treatment choice in the era of fiscal incentives: the case of the end-stage renal disease programR R Bovbjerg, P J Held, L H Diamond
Pageof 27

Showing results (111-120 of 268) with videos related to

Sort By:
Pageof 27
Clinical Journal of Oncology Nursing|May 8, 1999
Symptom management for patients with pancreatic cancerJ Held-Warmkessel, H Volpe, A R Waldman
Archives of Sexual Behavior|July 1, 1976
Follow-up effects of a medical school course in human sexualityJ Garrard, A Vaitkus, J Held, et al.
Journal of Policy Analysis and Management : [The Journal of the Association for Public Policy Analysis and Management]|February 4, 1988
Privatization and bidding in the health-care sectorR R Bovbjerg, P J Held, M V Pauly
American Journal of Industrial Medicine|January 1, 1988
Mortality of aircraft manufacturing workers in southern CaliforniaD H Garabrant, J Held, B Langholz, et al.
International Journal of Cancer|April 17, 2001
Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cellsR Mentlein, O Eichler, F Forstreuter, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 30, 2001
Calculation and public use of the unit-specific standardized mortality ratioR A Wolfe, P J Held, F K Port
Journal of Physiology, Paris|November 23, 2000
Somatostatin receptors in gliomasJ Held-Feindt, B Krisch, F Forstreuter, et al.
Journal of Cardiovascular Risk|August 1, 1995
Comparison of two scoring systems used to monitor diets in outpatient clinical trialsW S Harris, S J Held, C A Dujovne
Brain Research. Molecular Brain Research|February 27, 2001
Influence of the somatostatin receptor sst2 on growth factor signal cascades in human glioma cellsJ Held-Feindt, F Forstreuter, T Pufe, et al.
The Milbank Quarterly|January 1, 1987
Provider-patient relations and treatment choice in the era of fiscal incentives: the case of the end-stage renal disease programR R Bovbjerg, P J Held, L H Diamond
Pageof 27